140 related articles for article (PubMed ID: 9852393)
1. Bilateral oophorectomy in asymptomatic women over 50 years old selected by ovarian cancer screening.
Hayashi H; Yaginuma Y; Kitamura S; Saitou Y; Miyamoto T; Komori H; Wada K; Ishikawa M
Gynecol Obstet Invest; 1999; 47(1):58-64. PubMed ID: 9852393
[TBL] [Abstract][Full Text] [Related]
2. Ovarian cancer screening.
van Nagell JR; Gallion HH; Pavlik EJ; DePriest PD
Cancer; 1995 Nov; 76(10 Suppl):2086-91. PubMed ID: 8635005
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum CA 19-9 with adnexal mass: is it always an ovarian malignancy?
Chew KT; Zakaria IA; Abu MA; Ahmad MF; Hing EY; Abdul Ghani NA
Horm Mol Biol Clin Investig; 2018 Mar; 34(3):. PubMed ID: 29584612
[TBL] [Abstract][Full Text] [Related]
4. Is there any value in bimanual pelvic examination as a screening test.
Grover SR; Quinn MA
Med J Aust; 1995 Apr; 162(8):408-10. PubMed ID: 7746172
[TBL] [Abstract][Full Text] [Related]
5. Incidental adnexal masses detected at low-dose unenhanced CT in asymptomatic women age 50 and older: implications for clinical management and ovarian cancer screening.
Pickhardt PJ; Hanson ME
Radiology; 2010 Oct; 257(1):144-50. PubMed ID: 20663974
[TBL] [Abstract][Full Text] [Related]
6. [Program for early detection of ovarian cancer for women as prophylaxis provided at a municipal hospital].
Cnota W; Sodowski K; Olesiak-Andryszczak M; Pilch-Kowalczyk M
Wiad Lek; 2004; 57 Suppl 1():43-7. PubMed ID: 15884203
[TBL] [Abstract][Full Text] [Related]
7. Outcome of surveillance and prophylactic salpingo-oophorectomy in asymptomatic women at high risk for ovarian cancer.
Meeuwissen PA; Seynaeve C; Brekelmans CT; Meijers-Heijboer HJ; Klijn JG; Burger CW
Gynecol Oncol; 2005 May; 97(2):476-82. PubMed ID: 15863147
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer.
van Nagell JR; DePriest PD; Reedy MB; Gallion HH; Ueland FR; Pavlik EJ; Kryscio RJ
Gynecol Oncol; 2000 Jun; 77(3):350-6. PubMed ID: 10831341
[TBL] [Abstract][Full Text] [Related]
9. Is three-dimensional ultrasonography of additional value in the assessment of adnexal masses?
Geomini PM; Coppus SF; Kluivers KB; Bremer GL; Kruitwagen RF; Mol BW
Gynecol Oncol; 2007 Jul; 106(1):153-9. PubMed ID: 17493667
[TBL] [Abstract][Full Text] [Related]
10. Ovarian cancer screening in women with a family history of breast or ovarian cancer.
Lacey JV; Greene MH; Buys SS; Reding D; Riley TL; Berg CD; Fagerstrom RM; Hartge P
Obstet Gynecol; 2006 Nov; 108(5):1176-84. PubMed ID: 17077240
[TBL] [Abstract][Full Text] [Related]
11. [Adnexal tumors after surgical treatment of colorectal cancer].
Gottwald L; Korczyński J; Góra E; Bieńkiewicz A
Ginekol Pol; 2008 Apr; 79(4):259-63. PubMed ID: 18592863
[TBL] [Abstract][Full Text] [Related]
12. The Diagnostic Value of Transvaginal Sonograph (TVS), Color Doppler, and Serum Tumor Marker CA125, CEA, and AFP in Ovarian Cancer.
Zhang F; Zhang ZL
Cell Biochem Biophys; 2015 Jun; 72(2):353-7. PubMed ID: 25582421
[TBL] [Abstract][Full Text] [Related]
13. The risk of malignancy index in discrimination of adnexal masses.
Ulusoy S; Akbayir O; Numanoglu C; Ulusoy N; Odabas E; Gulkilik A
Int J Gynaecol Obstet; 2007 Mar; 96(3):186-91. PubMed ID: 17280665
[TBL] [Abstract][Full Text] [Related]
14. Cancer screening and risk-reducing behaviors of women seeking genetic cancer risk assessment for breast and ovarian cancers.
MacDonald DJ; Sarna L; Uman GC; Grant M; Weitzel JN
Oncol Nurs Forum; 2006 Nov; 33(2):E27-35. PubMed ID: 16518435
[TBL] [Abstract][Full Text] [Related]
15. Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing.
Schwartz MD; Kaufman E; Peshkin BN; Isaacs C; Hughes C; DeMarco T; Finch C; Lerman C
J Clin Oncol; 2003 Nov; 21(21):4034-41. PubMed ID: 14581427
[TBL] [Abstract][Full Text] [Related]
16. Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125.
Van Calster B; Timmerman D; Bourne T; Testa AC; Van Holsbeke C; Domali E; Jurkovic D; Neven P; Van Huffel S; Valentin L
J Natl Cancer Inst; 2007 Nov; 99(22):1706-14. PubMed ID: 18000221
[TBL] [Abstract][Full Text] [Related]
17. Role of laparoscopy in the evaluation of the adnexa in patients with stage IV breast cancer.
Quan ML; Fey J; Eitan R; Abu-Rustum NR; Barakat RR; Borgen PI; Gemignani ML
Gynecol Oncol; 2004 Jan; 92(1):327-30. PubMed ID: 14751178
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of adnexal masses with three-dimensional ultrasonography.
Geomini PM; Kluivers KB; Moret E; Bremer GL; Kruitwagen RF; Mol BW
Obstet Gynecol; 2006 Nov; 108(5):1167-75. PubMed ID: 17077239
[TBL] [Abstract][Full Text] [Related]
19. [Role of Ca-125 in the differential diagnosis of adnexal mass in breast cancer patients].
Grabiec M; Nowicki P; Walentowicz M; Greźlikowska U; Mierzwa T; Chmielewska W
Ginekol Pol; 2005 May; 76(5):371-6. PubMed ID: 16145856
[TBL] [Abstract][Full Text] [Related]
20. Ovarian masses in children and adolescents - an analysis of 521 clinical cases.
Zhang M; Jiang W; Li G; Xu C
J Pediatr Adolesc Gynecol; 2014 Jun; 27(3):e73-7. PubMed ID: 24157281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
